Markets

Stocks Most Likely to Beat Earnings for the week of February 13th

Here are four Zacks Rank #1 (Strong Buy) stocks that are likely to beat earnings for the week of February 13 th :

Ultra Clean Holdings, Inc. (UCTT): This manufacturer of production tools, modules, and subsystems has witnessed the Zacks Consensus Estimate for its current year earnings surging 5.8% over the last 60 days.

Ultra Clean Holdings, Inc. Price and Consensus

Ultra Clean Holdings, Inc. Price and Consensus | Ultra Clean Holdings, Inc. Quote

The company is expected to report its earnings results for the quarter ending December on Feb 22 and has an Earnings ESP of +7.41%. It has delivered positive earnings surprises in three out of four trailing quarters.

Ultra Clean Holdings, Inc. Price and EPS Surprise

Ultra Clean Holdings, Inc. Price and EPS Surprise | Ultra Clean Holdings, Inc. Quote

Applied Optoelectronics, Inc . (AAOI): This manufacturer and seller of fiber-optic networking products has witnessed the Zacks Consensus Estimate for its current year earnings surging 17.5% over the last 60 days.

Applied Optoelectronics, Inc. Price and Consensus

Applied Optoelectronics, Inc. Price and Consensus | Applied Optoelectronics, Inc. Quote

The company is expected to report its earnings results for the quarter ending December on Feb 23 and has an Earnings ESP of +15.87%. It has delivered positive earnings surprises in three out of four trailing quarters.

Applied Optoelectronics, Inc. Price and EPS Surprise

Applied Optoelectronics, Inc. Price and EPS Surprise | Applied Optoelectronics, Inc. Quote

Milacron Holdings Corp . (MCRN): This manufacturer of engineered and customized systems has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.5% over the last 60 days.

Milacron Holdings Corp. Price and Consensus

Milacron Holdings Corp. Price and Consensus | Milacron Holdings Corp. Quote

The company is expected to report its earnings results for the quarter ending December on Feb 23 and has an Earnings ESP of +11.43%. It has delivered positive earnings surprises in two out of four trailing quarters.

Milacron Holdings Corp. Price and EPS Surprise

Milacron Holdings Corp. Price and EPS Surprise | Milacron Holdings Corp. Quote

Dicerna Pharmaceuticals, Inc. (DRNA): This biopharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings advancing 0.3% over the last 60 days.

Dicerna Pharmaceuticals, Inc. Price and Consensus

Dicerna Pharmaceuticals, Inc. Price and Consensus | Dicerna Pharmaceuticals, Inc. Quote

The company is expected to report its earnings results for the quarter ending December on Mar 9 and has an Earnings ESP of +4.11%. It has delivered positive earnings surprises in all four trailing quarters.

Dicerna Pharmaceuticals, Inc. Price and EPS Surprise

Dicerna Pharmaceuticals, Inc. Price and EPS Surprise | Dicerna Pharmaceuticals, Inc. Quote

See the full list of top ranked stocks here .

Learn more about Earnings ESP and how you can make it a part of your investing strategy here .

Zacks' Top 10 Stocks for 2017

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2017?

Who wouldn't? Last year's market-beating Top 10 portfolio produced 5 double-digit winners. For example, oil and natural gas giant Pioneer Natural Resources and First Republic Bank racked up stellar gains of +44.9% and +44.3% respectively. Now a brand-new list for 2017 has been hand-picked from 4,400 companies covered by the Zacks Rank. See the 2017 Top 10 right now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Ultra Clean Holdings, Inc. (UCTT): Free Stock Analysis Report

Milacron Holdings Corp. (MCRN): Free Stock Analysis Report

Dicerna Pharmaceuticals, Inc. (DRNA): Free Stock Analysis Report

Applied Optoelectronics, Inc. (AAOI): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

UCTT AAOI DRNA

Other Topics

Earnings

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More